Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

The Radiologist's Approach to Assessing Cancer Risk of Thyroid Nodul…

Penn Medicine

J. Langer

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

Cancer Screening Molecular Tools

Fengting Yan

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

Year in Review: Precision Medicine

Vivek Subbiah

Nasopharyngeal Carcinoma: Clinical Overview & Disease Management

Ammar Sukari

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

Parathyroid Disease and Tumors

Yale Cancer Center

C. Gibson

Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

The Approach to a Patient with a Thyroid Nodule: Updating "The Bethe…

Penn Medicine

Z. Baloch

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib …

Insights from 2023 ASCO® Annual Meeting

V. Subbiah

Recent Advances in Treatment of Thyroid Cancer With Precision Medici…

Jefferson Health

M. Brose